معرفی
Mikkel Bruhn Schuster is a Senior Researcher at the Biotech Research and Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences at the University of Copenhagen, where he works in the Porse Group. His research focuses on molecular mechanisms of hematopoiesis and leukemia development.
Education:
- Ph.D. in Molecular Biology, University of Copenhagen (2004)
- M.Sc. in Molecular Biology, University of Copenhagen (1997)
Dr. Schuster's research centers on C/EBPa in normal hematopoiesis and leukemia, with specific interests in determinants of the pre-leukemic state in mice with Cebpa mutations, secondary events in transformation of pre-malignant cells into leukemia, and post-translational regulation of C/EBPa. His work bridges molecular biology, epigenetics, and cancer research with strong emphasis on hematopoietic stem cells and cancer stem cells.
His recent publications demonstrate consistent focus on acute myeloid leukemia mechanisms, epigenetic regulation, and hematopoietic differentiation. Key trends include investigation of transcription factor networks, chromatin modifications in leukemia, and molecular events driving leukemic transformation from pre-malignant states.
Dr. Schuster maintains active research output with multiple high-impact publications in journals such as Nature Communications, Leukemia, and Science Advances. His work shows significant collaborative networks within the University of Copenhagen and international research institutions, with evidence of social media dissemination and patent references.
Based at BRIC, Ole Maaløes Vej 5 in Copenhagen, he contributes to the Porse Group's research infrastructure focused on hematopoietic stem cell biology and leukemia research.
